Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 4/20 | 0.46 |
| ▸ | WNT3A | P56704 | 3/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1930231 | 0.98 | LMNA (0.52) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| Iodide SCHEMBL31327468 | 0.98 | LMNA (0.52) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| Bromide SCHEMBL7770547 | 0.98 | KMT2A (0.53) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| Bromide SCHEMBL5899856 | 0.98 | LMNA (0.52) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| Bromide SCHEMBL5900356 | 0.97 | KMT2A (0.51) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| Iodide SCHEMBL5956032 | 0.79 | PABPC1 (0.53) | LMNAL3MBTL1KMT2AKDM4EMEN1 | |
| Bromide SCHEMBL3894863 | 0.76 | KMT2A (0.53) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| Hydrochloric Acid SCHEMBL2527501 | 0.76 | KMT2A (0.73) | LMNAKMT2AKDM4ECES1MEN1 | |
| SCHEMBL253276 | 0.75 | CES2 (0.64) | LMNAL3MBTL1NAPRTP4HTMKMT2A | |
| SCHEMBL2470002 | 0.75 | CTNNB1 (0.71) | LMNAL3MBTL1NAPRTP4HTMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023092612-A1 | TWO-DIMENSIONAL COORDINATION POLYMER BASED ON ISOCYANO COORDINATION | 上海交通大学 | 2023-06-01 | — | — | WO | disclosed |
| US-20230159710-A1 | Two-Dimensional Coordination Polymer Based On Isocyano Coordination | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2023-05-25 | — | — | US | disclosed |
| US-20120100628-A1 | EMISSIVE AND BROADBAND NONLINEAR ABSORBING METAL COMPLEXES AND LIGANDS AS OLED, OPTICAL SWITCHING OR OPTICAL SENSING MATERIALS | NDSU RESEARCH FOUNDATION (US) | 2012-04-26 | — | — | US | disclosed |
| EP-2275409-A1 | Bipiridine derivative and organic electroluminescence element containing the same | Yamagata Promotional Organization for Industrial Technology (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-7465747-B2 | Fluorescent label compounds | Matsumoto, Kazuko (JP) | 2008-12-16 | — | — | US | disclosed |
| EP-1056771-B1 | STREPTOGRAMIN DERIVATIVES, PREPARATION METHOD AND COMPOSITIONS CONTAINING SAME | AVENTIS PHARMA SA (FR) | 2005-11-30 | — | — | EP | disclosed |
| EP-1056771-A1 | STREPTOGRAMIN DERIVATIVES, PREPARATION METHOD AND COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999043699-A1 | STREPTOGRAMIN DERIVATIVES, PREPARATION METHOD AND COMPOSITIONS CONTAINING SAME | AVENTIS PHARMA S.A. (FR) | 1999-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100628-A1 | EMISSIVE AND BROADBAND NONLINEAR ABSORBING METAL COMPLEXES AND LIGANDS AS OLED, OPTICAL SWITCHING OR OPTICAL SENSING MATERIALS | OCIAD2, OCIAD1, NONO | LMNA 4358/4885L3MBTL1 1175/4885NAPRT 552/4885 |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | NFE2L2, SLC19A2, AOC2 | LMNA 3042/4885L3MBTL1 3143/4885NAPRT 4157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.